GEODE CAPITAL MANAGEMENT, LLC - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 21 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$203,000
-18.8%
727,641
+9.4%
0.00%
Q1 2022$250,000
-46.2%
665,156
-41.0%
0.00%
Q4 2021$465,000
+54.5%
1,126,509
+126.8%
0.00%
Q3 2021$301,000
+1154.2%
496,757
+3064.7%
0.00%
Q2 2021$24,000
-31.4%
15,6970.0%0.00%
Q1 2021$35,0000.0%15,6970.0%0.00%
Q4 2020$35,00015,6970.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q2 2022
NameSharesValueWeighting ↓
Campion Asset Management 90,612$34,0000.03%
Virtu Financial LLC 112,255$42,0000.00%
Ratio Wealth Group 22,500$8,4600.00%
TWO SIGMA SECURITIES, LLC 118,890$45,0000.00%
Renaissance Technologies 1,801,200$677,0000.00%
Advisory Services Network, LLC 50,525$19,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
JANE STREET GROUP, LLC 49,730$19,0000.00%
UBS Group AG 54,955$21,0000.00%
IFP Advisors, Inc 4,000$26,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders